A new study by Mount Sinai researchers reveals how psychedelics target a specific serotonin receptor, 5-HT1A, to potentially treat disorders…
A study at the Icahn School of Medicine has uncovered that asenapine, an antipsychotic medication, may work through the TAAR1…
This website uses cookies.